Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on Capital EmployedReturn on Invested CapitalTimes Interest Earned

Lifecore Biomedical, Inc. \De\ (LFCR) Return on Equity (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Return on Equity over the past 15 years, most recently at 0.0% for Q1 2025.

  • Quarterly results put Return on Equity at 0.0% for Q1 2025, down 4.0% from a year ago — trailing twelve months through Feb 2025 was 0.0% (down 4.0% YoY), and the annual figure for FY2024 was 0.76%, up 160.0%.
  • Return on Equity for Q1 2025 was 0.0% at Lifecore Biomedical, Inc. \De\, down from 0.15% in the prior quarter.
  • Over the last five years, Return on Equity for LFCR hit a ceiling of 4.22% in Q4 2023 and a floor of 2.29% in Q2 2023.
  • Median Return on Equity over the past 5 years was 0.07% (2021), compared with a mean of 0.02%.
  • Biggest five-year swings in Return on Equity: skyrocketed 506bps in 2023 and later tumbled -408bps in 2024.
  • Lifecore Biomedical, Inc. \De\'s Return on Equity stood at 0.31% in 2021, then tumbled by -171bps to 0.83% in 2022, then skyrocketed by 606bps to 4.22% in 2023, then plummeted by -97bps to 0.15% in 2024, then tumbled by -100bps to 0.0% in 2025.
  • The last three reported values for Return on Equity were 0.0% (Q1 2025), 0.15% (Q4 2024), and 0.22% (Q3 2024) per Business Quant data.